Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Neurocognitive impairment and neuroCART.

Wright E.

Curr Opin HIV AIDS. 2011 Jul;6(4):303-8. doi: 10.1097/COH.0b013e3283477c46. Review.

PMID:
21546833
[PubMed - indexed for MEDLINE]
2.

Neurocognitive dysfunction in the highly active antiretroviral therapy era.

Mothobi NZ, Brew BJ.

Curr Opin Infect Dis. 2012 Feb;25(1):4-9. doi: 10.1097/QCO.0b013e32834ef586. Review.

PMID:
22156897
[PubMed - indexed for MEDLINE]
3.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
[PubMed - indexed for MEDLINE]
4.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
[PubMed - indexed for MEDLINE]
5.

Effects of antiretroviral therapy on cognitive impairment.

Liner KJ 2nd, Hall CD, Robertson KR.

Curr HIV/AIDS Rep. 2008 May;5(2):64-71. Review.

PMID:
18510891
[PubMed - indexed for MEDLINE]
6.

Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Wright EJ.

Curr Opin HIV AIDS. 2009 Sep;4(5):447-52. doi: 10.1097/COH.0b013e32832dd0c2. Review.

PMID:
20048710
[PubMed - indexed for MEDLINE]
7.

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

Cysique LA, Brew BJ.

Neuropsychol Rev. 2009 Jun;19(2):169-85. doi: 10.1007/s11065-009-9092-3. Epub 2009 May 9. Review.

PMID:
19424802
[PubMed - indexed for MEDLINE]
8.

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

Taiwo B, Hicks C, Eron J.

J Antimicrob Chemother. 2010 Jun;65(6):1100-7. doi: 10.1093/jac/dkq096. Epub 2010 Mar 25. Review.

PMID:
20348088
[PubMed - indexed for MEDLINE]
Free Article
9.

Improvements in antiretroviral therapy outcomes over calendar time.

Boyd MA.

Curr Opin HIV AIDS. 2009 May;4(3):194-9. doi: 10.1097/COH.0b013e328329fc8d. Review.

PMID:
19532050
[PubMed - indexed for MEDLINE]
10.

CSF penetration by antiretroviral drugs.

Eisfeld C, Reichelt D, Evers S, Husstedt I.

CNS Drugs. 2013 Jan;27(1):31-55. doi: 10.1007/s40263-012-0018-x. Review.

PMID:
23160938
[PubMed - indexed for MEDLINE]
11.

Protease inhibitor monotherapy and the CNS: peace of mind?

Perez-Valero I, Bayon C, Cambron I, Gonzalez A, Arribas JR.

J Antimicrob Chemother. 2011 Sep;66(9):1954-62. doi: 10.1093/jac/dkr229. Epub 2011 Jun 13. Review.

PMID:
21672918
[PubMed - indexed for MEDLINE]
Free Article
12.

Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.

Letendre S.

Top Antivir Med. 2011 Nov;19(4):137-42. Review.

PMID:
22156215
[PubMed - indexed for MEDLINE]
Free Article
13.

Pathogenesis of HIV in the central nervous system.

Valcour V, Sithinamsuwan P, Letendre S, Ances B.

Curr HIV/AIDS Rep. 2011 Mar;8(1):54-61. doi: 10.1007/s11904-010-0070-4. Review.

PMID:
21191673
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
[PubMed - indexed for MEDLINE]
15.

Early antiretroviral therapy: the role of cohorts.

Sabin CA.

Curr Opin HIV AIDS. 2009 May;4(3):200-5. doi: 10.1097/COH.0b013e32832c06ad. Review.

PMID:
19532051
[PubMed - indexed for MEDLINE]
16.

Role of interleukin-2 in patients with HIV infection.

Pett SL, Kelleher AD, Emery S.

Drugs. 2010 Jun 18;70(9):1115-30. doi: 10.2165/10898620-000000000-00000. Review.

PMID:
20518579
[PubMed - indexed for MEDLINE]
17.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
18.

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review.

Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ.

J Neurovirol. 2010 Mar;16(2):101-14. doi: 10.3109/13550281003682513. Review.

PMID:
20345318
[PubMed - indexed for MEDLINE]
19.

HIV infection and psychiatric illness.

Owe-Larsson B, Säll L, Salamon E, Allgulander C.

Afr J Psychiatry (Johannesbg). 2009 May;12(2):115-28. Review.

PMID:
19582313
[PubMed - indexed for MEDLINE]
Free Article
20.

Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Gannon P, Khan MZ, Kolson DL.

Curr Opin Neurol. 2011 Jun;24(3):275-83. doi: 10.1097/WCO.0b013e32834695fb. Review.

PMID:
21467932
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk